UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Fluticasone/Formoterol Combination Therapy Compared With Monotherapy in Adolescent and Adult Patients With Mild to Moderate Asthma

Clinical therapeutics, 2013-07, Vol.35 (7), p.950-966

2013

Volltextzugriff (PDF)

Asthma Management Costs With Feno In Addition To Standard Guidelines

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB85-AB85

2014

Volltextzugriff (PDF)

Validation of a New Portable Exhaled Nitric Oxide Analyzer, NIOX VERO®: Randomized Studies in Asthma

Pulmonary therapy, 2017-06, Vol.3 (1), p.207-218

2017

Volltextzugriff (PDF)

Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma

The New England journal of medicine, 2019-09, Vol.381 (13), p.1227-1239

2019

Volltextzugriff (PDF)

Patient-Reported Outcomes And Quality Of Life Improvements In Patients With Asthma Receiving A New, Breath-Actuated Beclomethasone Dipropionate Inhaler

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB62-AB62

2018

Volltextzugriff (PDF)

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis

Annals of allergy, asthma, & immunology, 2003-02, Vol.90 (2), p.214-222

2003

Volltextzugriff (PDF)

Rapid Onset of Action on Nasal Symptoms and Ocular Symptom Improvement With Olopatadine/Mometasone Combination Nasal Spray in Patients With Seasonal Allergic Rhinitis

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB170-AB170

2018

Volltextzugriff (PDF)

Fractional Exhaled Nitric Oxide (FeNO) Measurements with the NIOX VERO® in Children 4 to 6 Years Old using the 6 and 10 Second Exhalation Modes

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB104-AB104

2018

Volltextzugriff (PDF)

Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients

Respiratory medicine, 2014-08, Vol.108 (8), p.1171-1179

2014

Volltextzugriff (PDF)

Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis

Allergy and asthma proceedings, 2017-05, Vol.38 (3), p.222

2017

Volltextzugriff (PDF)

Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis

Allergy & rhinology (Providence, R.I.), 2010-03, Vol.31 (2), p.132-14

2010

Volltextzugriff (PDF)

Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis

Allergy and asthma proceedings, 2012-05, Vol.33 (3), p.249

2012

Volltextzugriff (PDF)

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma

Annals of allergy, asthma, & immunology, 2005-04, Vol.94 (4), p.465-472

2005

Volltextzugriff (PDF)

Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis

Allergy and asthma proceedings, 2014-07, Vol.35 (4), p.338

2014

Volltextzugriff (PDF)

Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis

Journal of allergy and clinical immunology, 1997-07, Vol.100 (1), p.110-121

1997

Volltextzugriff (PDF)

Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect

International journal of chronic obstructive pulmonary disease, 2014-01, Vol.9, p.919-925

2014

Volltextzugriff (PDF)

Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine

Annals of allergy, asthma, & immunology, 2004-08, Vol.93 (2), p.154-159

2004

Volltextzugriff (PDF)

Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis

Allergy and asthma proceedings, 2011-03, Vol.32 (2), p.151

2011

Volltextzugriff (PDF)

Once-daily indacaterol 75 µg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect

International journal of chronic obstructive pulmonary disease, 2014-01, Vol.9 (default), p.919-925

2014

Volltextzugriff (PDF)

Growth in asthmatic children treated with fluticasone propionate

The Journal of pediatrics, 1998-03, Vol.132 (3), p.472-477

1998

Volltextzugriff (PDF)

Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids

Annals of allergy, asthma, & immunology, 2006, Vol.96 (1), p.51-59

2006

Volltextzugriff (PDF)

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.1233-1243

2016

Volltextzugriff (PDF)

Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis

American journal of rhinology, 2005-11, Vol.19 (6), p.591-598

2005

Volltextzugriff (PDF)

Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma

The lancet child & adolescent health, 2021-12, Vol.5 (12), p.862-872

2021

Volltextzugriff (PDF)

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

Annals of allergy, asthma, & immunology, 2002-06, Vol.88 (6), p.592-600

2002

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Journals Archiv - DFG Nationallizenzen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fluticasone/Formoterol Combination Therapy Compared With Monotherapy in Adolescent and Adult Patients With Mild to Moderate Asthma

Asthma Management Costs With Feno In Addition To Standard Guidelines

Validation of a New Portable Exhaled Nitric Oxide Analyzer, NIOX VERO®: Randomized Studies in Asthma

Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma

Patient-Reported Outcomes And Quality Of Life Improvements In Patients With Asthma Receiving A New, Breath-Actuated Beclomethasone Dipropionate Inhaler

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis

Rapid Onset of Action on Nasal Symptoms and Ocular Symptom Improvement With Olopatadine/Mometasone Combination Nasal Spray in Patients With Seasonal Allergic Rhinitis

Fractional Exhaled Nitric Oxide (FeNO) Measurements with the NIOX VERO® in Children 4 to 6 Years Old using the 6 and 10 Second Exhalation Modes

Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients

Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis

Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis

Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma

Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis

Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis

Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect

Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine

Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis

Once-daily indacaterol 75 µg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect

Growth in asthmatic children treated with fluticasone propionate

Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis

Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

Aktive Filter

Suchergebnisse filtern